Xcell Amnio Matrix™ is a lyophilized amniotic membrane allograft designed to accelerate wound healing by delivering essential amino acids directly to the wound bed. This advanced matrix supports cellular repair and regeneration while maintaining a moist wound environment. No rehydration required. Available in sizes from 2×2 cm to 4×7 cm with room temperature storage — making it one of the most practice-friendly amniotic products available.

AmchoPlast is a dual-layer amnion-chorion allograft (dehydrated human amnion/chorion membrane — dHAICM) engineered to provide structural support and biological signaling for tissue repair. HCPCS: Q-4316. Processed to preserve the natural integrity of both placental layers, AmchoPlast offers a rich matrix of growth factors and cytokines that promote healing while minimizing inflammation and scar tissue formation. Its three-layer composition provides both a protective barrier and a concentrated regenerative environment at the wound site.

Amniotic membrane allografts are indicated for a broad range of wound care and surgical applications — including chronic wounds (DFU, VLU, pressure injuries), surgical wounds (post-operative incisions, wound dehiscence), burn wounds, and tissue repair in orthopedic, ophthalmologic, and reconstructive settings. The extracellular matrix and growth factor profile supports tissue regeneration, modulates inflammation, and provides a biological scaffold for cellular repair.

Every amniotic membrane product in our portfolio is supported by comprehensive compliance infrastructure — including payer-aligned documentation protocols, HCPCS coding guidance, coverage verification support, and proactive audit-readiness monitoring. We ensure that product utilization is documented in full compliance with CMS and commercial payer requirements, protecting your practice from unnecessary audit exposure.